HealthDay - SUNDAY, March 30 (HealthDay News) -- A divided cardiology
community is trying once again to make sense of a trial showing that a
drug can lower levels of "bad" LDL thin and yet give no apparent
benefit to people at high risk of heart attack and other cardiovascular
problems.

More: - Continued here